-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 18, Nanjing Chia Tai Tianqing submitted an application for the imitation of 4 types of sacubitril and valsartan sodium tablets
Figure 1: The latest product information declared by Nanjing Chia Tai Tianqing
Source: CDE official website
Sacubitril and Valsartan Sodium Tablets is an angiotensin II receptor blocker developed by Novartis.
Figure 2: Sales of Novartis' sacubatril and valsartan sodium tablets in the retail market (unit: ten thousand yuan)
Source: China City Entity Pharmacy Database of Meinenet
According to data from Meinnet.
Table 1: The status of the listing application under review earlier
Source: Meinenet MED2.
The hot sales of the original research products in the global market and the domestic market have attracted the attention of many domestic pharmaceutical companies.
Source: CDE official website, Minet database
The review data statistics are as of September 22, if there are any errors or omissions, please correct me